In the published article, there was an error in Table 1 as published due to erroneous data entry. The reported NIHSS in the table for the male participants is 14 (10; 15) and it is 14 (8; 15) for the female, p = 0.88. The correct number for the male participants is 8 (4; 13) and for the female it is 10 (5; 15), p = 0.09. The corrected Table 1 and its caption appears below.
Table 1
| Male | Female | P-value | |
|---|---|---|---|
| (n = 226) | (n = 175) | ||
| Mean age (SD) | 76.9 (8.3) | 81.9 (7.4) | <0.001 |
| Modified Rankin Scale | 0 (0; 1) | 1 (0; 2) | <0.001 |
| Comorbidity scores | |||
| Â Â Â Â Median Charlson Comorbidity Index (IQR) | 1 (0; 3) | 1 (0; 2) | 0.62 |
| Â Â Â Â Median CHA2DS2-VASc (IQR) | 2 (1; 3) | 2 (1; 3) | 0.74 |
| Medicine | |||
| Â Â Â Â NOAC | 60 (26.5 %) | 69 (39.4 %) | 0.009 |
| Â Â Â Â VKA | 166 (73.5 %) | 106 (60.6 %) | |
| Â Â Â Â Antiplatelets | 40 (18.6 %) | 16 (9.9 %) | 0.03 |
| Â Â Â Â Antihypertensives | 156 (71.9 %) | 123 (75.9 %) | 0.44 |
| Â Â Â Â Lipid lowering agents | 94 (43.9 %) | 48 (29.6 %) | 0.006 |
| Â Â Â Â Selective serotonin reuptake inhibitors | 14 (6.5 %) | 20 (12.3 %) | 0.08 |
| Smoking status | |||
| Â Â Â Â Active smoker | 22 (13.1 %) | 10 (7.8 %) | <0.001 |
| Â Â Â Â Former smoker | 80 (47.6 %) | 37 (28.7 %) | |
| Â Â Â Â Never smoker | 66 (39.3 %) | 82 (63.6 %) | |
| Alcohol/ drug use | |||
| Â Â Â Â No alcohol use | 42 (25.5 %) | 54 (44.3 %) | <0.001 |
| Â Â Â Â Below 14 units per week | 89 (53.9 %) | 63 (51.6 %) | |
| Â Â Â Â Above 14 units per week | 34 (20.6 %) | 5 (4.1 %) | |
| Â Â Â Â Alcohol dependency | 20 (8.8 %) | 2 (1.1 %) | 0.002 |
| Stroke severity scores | |||
| Â Â Â Â Admission Glasgow Coma Scale | 14 (10; 15) | 14 (8; 15) | 0.03 |
| Â Â Â Â Admission NIHSS | 8 (4; 13) | 10 (5; 15) | 0.09 |
| Systolic blood pressure limit order, n (%)a | |||
| Â Â Â Â <140 mmHg | 53 (23.5 %) | 42 (24.0 %) | 0.99 |
|     140–160 mmHg | 27 (11.9 %) | 21 (12.0 %) | |
|     160–180 mmHg | 4 (1.8 %) | 2 (1.1 %) | |
| Â Â Â Â No limit ordered | 142 (62.8 %) | 110 (62.9 %) | |
| Radiology | |||
| Â Â Â Â Median hematoma volume, mL (IQR) | 22.2 (4.6; 64.6) | 19.1 (4.6; 63.8) | 0.90 |
Baseline data in 401 men and women with oral anticoagulant (OAC)-related intracerebral hemorrhage (ICH).
OAC, oral anticoagulant; ICH, intracerebral hemorrhage; SD, standard deviation; IQR, interquartile range; NIHSS, National Institute of Health Stroke Scale; mmHg, millimeter of mercury.
Number of patients with a systolic blood pressure limit order in the patient file.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Summary
Keywords
stroke, sex-differences, ICH, oral anticoagulation, vitamin K-antagonist, stroke in women, intracerebral hemorrhage (ICH), NOAC
Citation
Grundtvig J, Ovesen C, Steiner T, Carcel C, Gaist D, Christensen L, Marstrand J, Meden P, Rosenbaum S, Iversen HK, Kruuse C, Christensen T, Ægidius K, Havsteen I and Christensen H (2022) Corrigendum: Sex-differences in oral anticoagulant-related intracerebral hemorrhage. Front. Neurol. 13:1055360. doi: 10.3389/fneur.2022.1055360
Received
27 September 2022
Accepted
05 October 2022
Published
19 October 2022
Volume
13 - 2022
Edited and reviewed by
Svetlana Lorenzano, Sapienza University of Rome, Italy
Updates
Copyright
© 2022 Grundtvig, Ovesen, Steiner, Carcel, Gaist, Christensen, Marstrand, Meden, Rosenbaum, Iversen, Kruuse, Christensen, Ægidius, Havsteen and Christensen.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Josefine Grundtvig josefine.liv.gilling.grundtvig@regionh.dkHanne Christensen hanne.krarup.christensen@regionh.dk
This article was submitted to Neuroepidemiology, a section of the journal Frontiers in Neurology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.